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he signaling enzyme phospholipase D1 (PLD1) facili-
tates membrane vesicle trafﬁcking. Here, we explore
how PLD1 subcellular localization is regulated via
Phox homology (PX) and pleckstrin homology (PH) domains
and a PI4,5P
 
2
 
-binding site critical for its activation. PLD1
localized to perinuclear endosomes and Golgi in COS-7
cells, but on cellular stimulation, translocated to the
plasma membrane in an activity-facilitated manner and
then returned to the endosomes. The PI4,5P
 
2
 
-interacting
site sufﬁced to mediate outward translocation and association
with the plasma membrane. However, in the absence of PX
and PH domains, PLD1 was unable to return efﬁciently to
T
 
the endosomes. The PX and PH domains appear to facilitate
internalization at different steps. The PH domain drives
PLD1 entry into lipid rafts, which we show to be a step critical
for internalization. In contrast, the PX domain appears to
mediate binding to PI5P, a lipid newly recognized to accumu-
late in endocytosing vesicles. Finally, we show that the PH
domain–dependent translocation step, but not the PX domain,
is required for PLD1 to function in regulated exocytosis in
PC12 cells. We propose that PLD1 localization and function
involves regulated and continual cycling through a succession
of subcellular sites, mediated by successive combinations
of membrane association interactions.
 
Introduction
 
Phospholipase D1 (PLD1)* is activated in a variety of cell
types in response to hormone, neurotransmitter, and growth
factor–stimulated receptor signaling (Liscovitch et al., 2000),
and it hydrolyzes the membrane phospholipid phospha-
tidylcholine to generate phosphatidic acid (PA) and choline.
PA has been proposed to function as a lipid signal that activates
enzymes such as phosphatidylinositol 4-phosphate 5-kinase,
which generates PI4,5P
 
2
 
. It may also act as a lipid anchor
for a growing number of proteins involved in membrane
trafficking, as a physical regulator of membrane curvature,
or become further metabolized to diacylglycerol and lysoPA.
Although other functions have been proposed, cell biological
roles for PLD1 most commonly involve regulation of vesicu-
lar trafficking. Such roles include promoting outward traf-
ficking of secretory vesicles in neuroendocrine (Chen et al.,
1997), adipocyte (Emoto et al., 2000), or mast cells (Brown
et al., 1998; Choi et al., 2002), or the fusion of secretory
granules into the plasma membrane (PM) during regulated
exocytosis in neuroendocrine and neural cells (Humeau et
al., 2001; Vitale et al., 2001).
PLD1 exhibits a variable pattern of subcellular steady-state
localization that differs in different cell types. In COS-7 and
HeLa cells, PLD1 is found in perinuclear structures including
Golgi, early endosomes, late endosomes, and multi-vesicular
bodies/lysosomes (Colley et al., 1997; Freyberg et al., 2001;
Lucocq et al., 2001). A very small fraction of PLD1 is found
on the PM in these cells; however, PLD1 primarily localizes
to the PM in adrenal chromaffin and PC12 cells (Vitale et
al., 2001). Under stimulatory conditions in mast cells and
adipocytes, PLD1 colocalizes with secretory vesicles and
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translocates with them to the PM (Brown et al., 1998;
Emoto et al., 2000; Choi et al., 2002). This implies that
PLD1 must then return from the PM to intracellular vesi-
cles, and colocalization of PLD1 with internalized EGF re-
ceptor–containing endosomes has been described previ-
ously (Hughes and Parker, 2001). Together, these reports
suggest that the localization of the PLD1 is not static and
that regulated translocation and recycling may be crucial to
its proper functioning.
To begin to explore this issue, we undertook to determine
the mechanisms that target PLD1 to specific subcellular
compartments. The mechanisms were anticipated to be
complicated because PLD1 contains several potential mem-
brane association domains or motifs, including a pleckstrin
homology (PH) domain, a Phox homology (PX) domain,
and a putative PI4,5P
 
2
 
-interacting basic amino acid–rich
motif (Frohman et al., 1999), all of which have been dem-
onstrated to mediate membrane localization in other pro-
teins through binding to lipid or protein targets (for review
see Lemmon and Ferguson, 2000; Cockcroft and De Mat-
teis, 2001; Sato et al., 2001). In present paper, we show that
these domains appear to mediate distinct steps in the PLD1-
cycling pathway in response to dynamic changes in the cells.
 
Results
 
PLD1 localizes to perinuclear vesicles in COS-7 cells 
and translocates to the PM on cellular stimulation 
in an activity-facilitated manner
 
A typical perinuclear vesicular localization pattern for PLD1
in resting cells as reported previously by us and others (Frey-
berg et al., 2001; Lucocq et al., 2001) is shown in Fig. 1 A. A
subset of the vesicles colocalize with the transferrin receptor
(TfR), which is found in sorting/recycling endosomes (Fig. 1
B); others colocalize with EEA1, an early endosomal marker,
and some colocalization is also observed with GM130, a
Golgi marker. Infrequently (unpublished data), a small
amount of PLD1 is found on the PM. The relative distribu-
tion of wild-type PLD1 in serum-starved cells was deter-
mined by examining 300 cells. As shown in the left panel of
Fig. 1 E, PLD1 was exclusively found in such perinuclear
vesicles in 
 
 
 
90% of the cells. PMA stimulation, which acti-
vates PKC, resulted in translocation of most or all of the
PLD1 to the PM and peripheral vesicles (Fig. 1, C and C
 
 
 
)
in the majority of cells (
 
 
 
80%, Fig. 1 E) within 2 h. By 4 h
after stimulation, much of the PLD1 had returned to the
perinuclear vesicles (Fig. 1, D and E), although some residual
localization on the PM remained in some cells (Fig. 1 D
 
 
 
).
A similar pattern of localization was observed in serum-
starved cells for PLD1-K898R, a catalytically inactive allele
(Sung et al., 1997). However, substantially decreased translo-
cation to the PM occurred with PMA stimulation (summa-
rized in Fig. 1 E, right), indicating that the translocation is fa-
cilitated when PLD1 is capable of being activated. This is
consistent with several prior reports that increases in PLD1
activity facilitate vesicular trafficking, whereas the catalytically
inactive allele can act as a dominant-negative mutant (Chen et
al., 1997; Brown et al., 1998; Emoto et al., 2000; Humeau et
al., 2001; Vitale et al., 2001; Choi et al., 2002).
 
Summary of constructs
 
To delineate the mechanisms through which PLD1 becomes
targeted to different subcellular sites, we generated a series of
mutant alleles (Fig. 2). We focused on the four regions most
likely to mediate membrane association and specific subcel-
lular targeting: a PX domain, a PH domain, a PI4,5P
 
2
 
 bind-
ing motif, and the loop region of PLD1. The mutants were
confirmed to be expressed at similar levels and at the ex-
pected sizes (unpublished data), and except for the isolated
domains, were assayed for regulated activity in vitro us-
ing ARF1 as a stimulator. With one exception (PLD1
R691,695G, in which the PI4,5P
 
2
 
-binding site is disrupted),
all of the mutants were active at approximately wild-type
levels. It should be noted that it is relatively easy to destabi-
lize PLD1 through manipulations involving mutagenesis, re-
sulting in inactive, presumably substantially misfolded, and
mislocalized protein (Zhang et al., 1999; Du et al., 2000). A
number of variations on the constructs shown in Fig. 2 were
inactive and were discarded. Perhaps not surprisingly, the
exact boundaries at which deletions were made turned out to
be crucial to preserve enzymatic activity (and presumably,
Figure 1. PLD1 recycles between PM and intracellular vesicles 
in an activity-facilitated manner on PMA stimulation. COS-7 cells 
were transiently transfected with an HA-tagged PLD1 expression 
plasmid. 36 h later, the cells were stimulated with PMA for varying 
periods of time (A, C, and D) and then fixed and immunostained 
using an anti-HA mAb. Images were captured using a confocal 
microscope (TCS SP2; Leica) using a green fluorophore-labeled 
secondary antibody. Colocalization with EEA1, GM130, and TfR (B) 
was performed using far-red as the second fluorophore. On stimulation 
by PMA, PLD1 translocates to the PM; shown is a 2-h time point (C). 
C  and D  show additional images of cells in which translocation or 
return was not complete at the respective time points. E depicts a 
tabulation of percent localization for 300 cells at each time point, 
including SDs that were determined by conducting the experiment 
three times. Vesicles (V), plasma membrane (PM), and intermediate 
cells (PM/V) were scored as indicated by the labels in the bottom 
right corner of each image.T
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adequate folding). This issue could account for discrepancies
between our results and a report on mutagenesis of the
PLD1 PH domain in which the described mutations gener-
ated inactive alleles (Hodgkin et al., 2000).
A distinct structure in PLD1 consists of a central 138
amino acid “loop” region found in PLD1 (and 
 
Drosophila
 
and 
 
Caenorhabditis elegans
 
 PLD), but not in the other mam-
malian isoform, PLD2 (Hammond et al., 1995; Colley et
al., 1997). To examine this region for possible contributions
to PLD1’s pattern of localization, we characterized a mutant
allele lacking it (PLD1(
 
 
 
loop2)) that is expressed at wild-
type levels and is fully enzymatically active (Sung et al.,
1999b). However, it exhibited a wild-type localization pat-
tern (unpublished data), suggesting that it is not involved in
membrane localization.
 
A central basic amino acid–rich PI4,5P
 
2
 
-interacting site 
is required and suffices to promote PLD1 localization 
to the PM after cellular stimulation
 
The PLD1 NH
 
2
 
 terminus would be expected to play a role
in localization because it contains both PX and PH domains,
each of which have been shown to target many other pro-
teins to membranes through binding to lipid or protein tar-
gets. Indeed, a PLD1 allele lacking the PX- and PH-contain-
ing NH
 
2
 
 terminus (PLD1-
 
 
 
N) that is enzymatically active
(Sung et al., 1999b) is cytosolic in quiescent cells (Fig. 3 A),
demonstrating that the NH
 
2
 
 terminus is required for local-
ization to perinuclear membrane vesicles. However, on stim-
ulation by PMA, dramatic recruitment to the PM was ob-
served (in 
 
 
 
85% of the cells). Moreover, once recruited to
the PM, this mutant allele persistently localized there; no re-
entry into the cell was observed by 4 h after stimulation (Fig.
1, D and E). The first result indicates that the mechanism
responsible for PM recruitment does not involve the PX or
PH domain, leaving the potential PI4,5P
 
2
 
-interacting site as
the most likely candidate. The second result suggests that
the PX or PH domain mediates internalization.
Previously, we demonstrated that an arginine/lysine-rich
sequence found in the center of PLD2 (aa 554–575) and
conserved in PLD1 bound vesicles containing PI4,5P
 
2
 
 and
was responsible for the activation of PLD2 observed in the
presence of PI4,5P
 
2
 
 (Sciorra et al., 1999). On the other
hand, Wakelam and colleagues reported that the PI4,5P
 
2
 
-
interacting and activating site in PLD1 lies in its NH
 
2
 
-ter-
minal PH domain (Hodgkin et al., 2000). Therefore, we set
out to assess whether the PLD1 arginine/lysine-rich se-
quence (aa 691–712) is important for PI4,5P
 
2
 
-mediated
binding and activity, using an allele mutated at this site. We
found that the mutant PLD1 allele, PLD1-R691G,R695G,
exhibited only 5% of the wild-type PLD1 ARF1 simulated-
response in a PLD in vitro assay. Similar results were ob-
served using an in vivo PLD assay (unpublished data).
Moreover, we found that PLD1-R691G,R695G no longer
exhibits an increased affinity for PI4,5P
 
2
 
-containing lipid
vesicles (Fig. 3 B). In contrast, all of our PLD1 mutants
lacking the PH domain are still active and are still PI4,5P
 
2
 
-
dependent (Fig. 2; also see Sung et al., 1999b). Together
with the prior reports, we would conclude that PLD1, like
PLD2, is activated by interaction with PI4,5P
 
2
 
 at its central
arginine/lysine-rich sequence rather than through its NH
 
2
 
-
terminal PH domain.
Next, we examined subcellular localization of the PI4,5P
 
2
 
-
noninteracting mutant PLD1 allele in vivo. The PLD1
R691G,R695G mutant exhibited a complicated pattern of
localization: it still colocalized with wild-type PLD1 in peri-
Figure 2. Summary of the PLD1 constructs used in this paper. 
The constructs were NH2-terminally HA- or EGFP-tagged as indicated. 
See Results for details.
Figure 3. The NH2 terminus contains targeting signals for the 
endosomes and Golgi and is required for internalization, whereas 
the PI4,5P2-interacting motif mediates recruitment to the PM. 
(A and C) COS-7 cells were transiently transfected with deletion or 
mutated PLD1 constructs as shown in Fig. 2, and were processed as 
described in Fig. 1. In C, two examples are shown for each time point. 
(B) Characterization of the PLD1 PI4,5P2-binding motif. Wild-type 
(WT) and R691G,R695G (RG) mutant PLD1 proteins purified from 
baculovirus-infected sf9 cells were mixed with different amounts of 
liposomes containing PC, PE, and 5% PIP or 5% PI4,5P2. The vesicles 
were sedimented by centrifugation and the pellets were analyzed by 
Western blotting for cosedimentation of PLD1.T
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nuclear vesicles (Fig. 3 C, top serum-starved panel), suggest-
ing that the preferred site of membrane localization re-
mained unchanged. However, cytosolic localization was also
observed and in some cells dominated (Fig. 3 C, bottom se-
rum-starved panel), suggesting that PI4,5P
 
2
 
-interactions
contribute to the avidity of PLD1 perinuclear vesicular lo-
calization, although they are not strictly required. On PMA
stimulation, little recruitment to the PM was observed; in
fact, most of the protein relocated to the cytosol. This con-
firms that the PX and PH domains do not mediate PLD1
translocation to the PM under these circumstances, and that
the PI4,5P
 
2
 
-interacting site is critical.
The increased cytosolic localization of PLD1 R691G,
R695G in COS-7 cells was also confirmed using cell frac-
tionation by microcentrifugation. For wild-type PLD1, such
centrifugation suffices to pellet all of the enzyme (Zhang et
al., 1999). In contrast, part (
 
 
 
50%) of the PLD1-R691G,
R695G protein was not pelleted under these conditions, in-
dicating that a substantial portion of it is not in association
with membranes (unpublished data). This loss of associa-
tion does not ensue from its lack of activity because the cat-
alytically inactive mutant allele PLD1-K898R is membrane
associated similar to the wild-type protein (Zhang et al.,
1999).
 
The PLD1 PX domain regulates internalization 
potentially through a PI5P-dependent mechanism
 
The PX domain was initially defined as an 
 
 
 
120-amino acid
conserved region present in the p40
 
phox
 
 and p47
 
phox
 
 subunits
of NADPH oxidase (Ponting, 1996). Recent work from
many groups has revealed that PX domains, which are now
known to be present in more than 60 proteins, frequently
bind PI3P and PI3,4P
 
2
 
 and act as endosomal targeting do-
mains (for review see Sato et al., 2001). Some PX domains
have also been reported to bind PI4,5P
 
2
 
 or protein targets.
The PX domain plays a relatively subtle role in PLD1 lo-
calization in serum-starved cells (Fig. 4 A) because an allele
lacking the PX domain is still found in perinuclear vesicles.
However, the nature of the vesicles targeted appears to be
shifted because nearly uniform colocalization in sorting/re-
cycling endosomes was observed with the TfR and the dom-
inant-negative ARF6 mutant T27N (unpublished data; pat-
tern of localization of TfR and ARF6-T27N discussed in
D’Souza et al., 1995), but colocalization with GM130 or
EEA1 was decreased (unpublished data). However, more
obviously, the PLD1-
 
 
 
PX allele still underwent robust
translocation to the PM after PMA stimulation, but did not
undergo wild-type-like reentry (Fig. 4 A). Similar results
were observed for point mutants (R118, F120/R179) in the
PX domain at amino acid residues predicted to be required
for interaction with phosphoinositide lipid anchors (based
on the published structures of the p40 and p47 PX domains
and sequence alignment of the entire set of known PX do-
mains; for review see Sato et al., 2001). Together, these find-
ings suggest that the PX domain is required in a phospho-
inositide-dependent process for PLD1 to reenter COS-7 cells
once it has become localized to the PM.
Classical PX domains such as p40 bind PI3P, and
through this interaction localize to EEA1-containing endo-
somes (Kanai et al., 2001). This mechanism can be dem-
onstrated in NIH3T3 cells using p40PX-EGFP, which lo-
calizes to endosomes in a discrete punctate pattern that is
disrupted on addition of wortmannin, a specific inhibitor
of PI3 kinases (Fig. 5 C). The isolated PLD1-PX domain
localizes to cytosolic vesicles (Fig. 5 A), but colocalization
with EEA1 was not observed, suggesting that interaction
with PI3P does not underlie its targeting mechanism. Sup-
porting this observation, addition of wortmannin to the
transfected cells did not affect PLD1-PX domain localiza-
tion (Fig. 5 C). Moreover, mutation of R118 did not alter
localization in quiescent cells of either the isolated domain
or the full-length protein (Fig. 5 B), suggesting that the
targeting mechanism here is distinct from the potential
phosphoinositide-interacting one that regulates PLD1 re-
entry (Fig. 4 B). Finally, examination of the binding speci-
ficity of the PLD1-PX domain expressed and purified from
bacteria revealed a significant interaction with PI5P (Fig. 5
D), a PI that has recently been proposed to accumulate on
endocytic vesicles from the hydrolysis of PI4,5P
 
2
 
 (Terebiz-
nik et al., 2002).
 
The PLD1 PH domain also mediates internalization
 
PH domains are well known to bind different kinds of phos-
phoinositides; a minority of the domains bind through
strong and specific interactions; however, most of them
characteristically bind through nonspecific low affinity in-
teractions (Lemmon and Ferguson, 2000). In addition,
some PH domains bind protein targets. Such interactions
Figure 4. The PX domain is required for PLD1 internalization 
potentially through phosphoinositide interactions, but is not 
required for localization to at least some types of endosomes. 
COS-7 cells were transiently transfected with deletion or mutated 
PLD1 constructs as shown in Fig. 2, and were processed as described 
in Fig. 1. Two examples are shown for each time point to indicate 
how cells were scored.T
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sometimes serve to activate PH domain–containing pro-
teins, but most often assist in directing their correct localiza-
tion. As shown in Fig. 3 B, affinity for PI4,5P
 
2
 
 does not ap-
pear to represent a major component of the role of the
PLD1 PH domain.
A catalytically active PLD1-
 
 
 
PH allele exhibited cytosolic
localization (Fig. 6, A and B) and exhibited some (but not
complete) PMA-stimulated translocation to the PM fol-
lowed by delayed reentry. The lack of robust PMA-elicited
translocation (for example, in comparison to the PLD1-
 
 
 
N
allele described in Fig. 3, which lacks even more sequence)
suggests that the deletion of the PH domain may have af-
fected the functionality of the other domains, despite the
fact that catalytic activity was maintained.
Sugars et al. (1999) have reported that the PLD1 PH do-
main is palmitoylated at two cysteines (positions 240 and
241), and that the loss of this palmitoylation causes PLD1 to
translocate from perinuclear vesicles to the PM. Although
we would agree with this localization pattern in cells main-
tained in media containing 10% FCS (unpublished data),
we also observed that much of the PLD1 C240S/C241S lo-
calized to the cytosol in serum-starved cells (Fig. 6 C). How-
ever, robust translocation to the PM again with extended
Figure 5. The PX domain mediates endosomal association indepen-
dent of PI3 kinase products or lipid interactions, but may facilitate 
reentry through interaction with PI5P. (A and B) COS-7 cells were 
transiently transfected with wild-type or mutated full-length PLD1 or 
isolated PX domain constructs as shown in Fig. 2, and were processed 
as described in Fig. 1. (A) The isolated PLD1 PX domain localizes to 
cytosolic vesicles, but does not colocalize with EEA1 endosomes 
(or GM130, not depicted). Not depicted are similar results that were 
observed for the isolated domain and for the full NH2 terminus 
(1–212, which contains an extra 70 amino acids, as shown in Fig. 2). 
(C) COS-7 cells transiently transfected with p40 or PLD1 EGFP-PX 
domain constructs were followed over time after the addition of 
varying concentrations of wortmannin. (D) Purified bacterial Nus 
protein or Nus–PLD1 PX domain fusion protein was used to probe 
a set of phospholipids spotted on nitrocellulose strips, after which 
the proteins were detected using an anti-Nus mAb. Figure 6. The PLD1 PH domain targets endosomes in quiescent 
cells and mediates internalization from the PM through controlling 
entry into lipid rafts. COS-7 cells were transiently transfected with 
deletion or mutated PLD1 constructs as shown in Fig. 2, and were 
processed as described in Fig. 1. (A and B) Two examples are shown 
for the deletion construct at each time point. Where indicated (right-
most quantification panel), methyl- -cyclodextrin was added to the 
culture medium for 45 min and then thoroughly washed away before 
PMA stimulation.T
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persistence was observed after PMA stimulation. Zacharias
et al. (2002) have reported that the addition of two or more
palmitates to proteins drives their accumulation into lipid
rafts; wild-type PLD1 can also be found there (Kim et al.,
2000). Taking these observations together, we would pro-
pose that PLD1 can translocate to the PM even if lacking
palmitoylation, but cannot enter into lipid rafts, and that
entry into the rafts is a key step in the intracellular reentry
pathway.
To test the importance of lipid rafts for PLD1 trafficking,
we next examined whether preexposure of cells to methyl-
 
 
 
-cyclodextrin, an agent that disrupts lipid rafts, affected wild-
type PLD1 internalization. As shown in the summary in Fig.
6 (right), in cells lacking lipid rafts, PLD1 localized nor-
mally to perinuclear vesicles and translocated to the PM
with PMA stimulation, but was unable to cycle back to the
intracellular vesicles with normal kinetics. Together, these
findings demonstrate that entry of PLD1 into lipid rafts via
palmitoylation is a critical step in its cycling pathway.
The isolated PLD1 PH domain associates with mem-
branes weakly (Fig. 7). It localizes in resting cells to perinu-
clear membrane structures. With PMA, a very weak translo-
cation is observed to the PM (Fig. 7), suggesting that the PH
domain may contribute to a small degree to regulated trans-
location, although this is minor at best in the context of the
full-length protein (as shown in Fig. 3).
 
The PH domain–mediated translocation step into rafts 
is required for PLD1 facilitation of regulated exocytosis
 
Previously, we reported that PLD1 is expressed in neuroen-
docrine cells and facilitates regulated exocytosis of secretory
granules (Vitale et al., 2001). In the assay system used for
those analyses, the PC12 cells used were cultured in 15% se-
rum, and exocytosis was triggered by the elevation of potas-
sium, which induces depolarization. PLD1 localized to the
PM in these cells and increased exocytotic responses when
overexpressed, whereas the inactive allele, PLD1-K898R,
which localized similarly, inhibited exocytosis (Fig. 8; see
also Vitale et al., 2001). We also reported that interaction
with PI4,5P
 
2
 
 was potentially required for the PM localiza-
tion in nondepolarized cells because the PLD1-R691,695G
mutant allele localized to the cytosol and did not alter the
extent of exocytosis. Using some of the mutant alleles gener-
ated in this report, we now further examine in PC12 cells
whether the different PLD1 membrane-association motifs
control its subcellular distribution, and what the importance
of PLD1 localization is in regulating exocytosis.
As shown in Fig. 8, PLD1 localizes to the PM both before
and after depolarization. In contrast, the PLD1-
 
 
 
PX allele
localizes to the cytoplasm before depolarization, revealing
that it is a combination of PI4,5P
 
2
 
 and PX domain interac-
Figure 7. The isolated PLD1 PH domain associates only weakly 
with internal and plasma membranes, both in resting cells and 
stimulated cells. COS-7 cells were transfected with plasmids 
expressing the PH domain flanked by leader and trailing sequences.
Figure 8. PLD1 localization affects regulated exocytosis in PC12 
cells. PC12 cells were cotransfected with plasmids encoding hGH 
and tagged PLD1 alleles. 48 h after transfection, cells were incubated 
for 10 min in calcium-free Locke’s solution (nondepolarized) or in 59 
mM K
  solution (depolarized). (Top) Cells were immunostained to 
visualize the PLD1 protein by confocal microscopy. Bar, 5  m. 
(Bottom) Assay for regulated exocytosis. The total GH content in 
control and PLD1-expressing cells was in the range of 5 ng/well. The 
net K
 -evoked secretory response was obtained by subtracting the 
basal hGH release from the hGH release evoked by 59 mM K
 . In 
these experiments, basal release ranged from 5.0 to 5.7%. The net 
K
 -evoked GH release was 25.7%   0.4 from empty plasmid-trans-
fected control cells, and, depending on the allele, ranged from 12.8 
to 32.3% in PLD1-expressing cells. Finally, the net secretion under 
experimental conditions was divided by the net secretion in control 
cultures to estimate the percent change in regulated exocytosis. The 
experiments were performed twice in triplicate, and SEM is presented.T
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tions that targets PLD1 to the PM in this setting. However,
PLD1-
 
 
 
PX translocates to the PM and facilitates exocytosis
on depolarization, demonstrating that the PX domain is no
longer required for PM localization or function in secreta-
gogue-stimulated cells. This could be because the PI4,5P
 
2
 
interaction is strengthened (due to PI4,5P
 
2
 
 levels rising at
the PM on depolarization). Alternatively, PLD1 may shift to
a different subcompartment within the PM. The latter hy-
pothesis is supported by the results shown for the PLD1-
C240,241S allele. This allele is found at the PM in the non-
depolarized state, demonstrating that in this setting, the PX
and PI4,5P
 
2 
 
interactions suffice in the absence of palmitoyla-
tion to promote PM localization. However, on depolariza-
tion, the allele falls into the cytoplasm, indicating that the
PX and PI4,5P
 
2
 
 interactions no longer suffice to retain
PLD1 on the PM. Moreover, the lack of facilitation of exo-
cytosis by this allele reveals that it becomes mislocalized
without having the opportunity to mediate its normal func-
tional role in this event. Together, these results confirm that
a combination of three separate interaction mechanisms
(PX-, PH-, and PI4,5P
 
2
 
-interacting) regulates PLD1 local-
ization to the PM under resting and different stimulatory
conditions, and that this is important for its functional role.
 
Discussion
 
PLD1 cycles using a complex set of
membrane determinants
 
Cycling of PLD1 from perinuclear locations to the PM and
back may occur more commonly than had been appreciated.
We and others had reported translocation of PLD1 in sev-
eral specialized settings, such as insulin-stimulated adipo-
cytes (Emoto et al., 2000) and degranulating mast cells
(Choi et al., 2002), but in most reports, the localization has
been described as static in the face of agonist stimulation. In
establishing the system used for the experiments reported
here, we found that culture in 10% serum desensitized
COS-7 cells; robust translocation of PLD1 was best ob-
served subsequent to prior serum starvation. In fact, this is
the approach used to study Glut-4 glucose transporter trans-
location in adipocytes, and under similar conditions, we
have observed regulated cycling of PLD1 in response to both
receptor tyrosine kinase signaling (insulin receptor) and G
protein–coupled receptor signaling (angiotensin II; unpub-
lished data). The intracellular path taken by PLD1 is not
clear. In the resting state, PLD1 is found in a complex set of
vesicles including EEA1-containing endosomes, and TfR-,
dominant-negative ARF6-containing sorting/recycling vesi-
cles, suggesting that there may be both short and long routes
through which PLD1 cycles, as has been found for other cy-
cling transducers. PLD1 can also be found in the Golgi
compartment, adding to this complexity. It is not presently
clear which routes of trafficking are predominant.
Colocalization studies of PLD1 and Glut-4 containing
storage vesicles or mast cell granules have suggested that the
mechanism of PLD1 trafficking to the PM involves cotrans-
location on the vesicles themselves. However, the trafficking
step is not a passive one; in mast cells (Choi et al., 2002) and
as shown here for COS-7 cells (Fig. 1), PLD1 activity pro-
motes increased trafficking of the vesicles and thus the trans-
location/cycling of PLD1 is linked to its physiological func-
tioning.
In this paper, we examine the localization of wild-type
and mutant PLD1 alleles in different states of cellular activa-
tion in two different cell types. Three different domains or
motifs (PX-, PH-, and PI4,5P
 
2
 
-interacting) in PLD1 were
shown to affect PLD1 localization and translocation at dif-
ferent points in these states.
 
PI4,5P
 
2
 
 interaction through a central basic 
amino acid–rich motif
 
The observation that the allele lacking both the PX and PH
domains (PLD1-
 
 
 
N, Fig. 3 A) is in the cytosol in serum-
starved COS-7 cells but translocates to the PM on PMA
stimulation demonstrates that (1) the PX and PH domains
are required for localization to perinuclear vesicles in this
state; (2) the PI4,5P
 
2
 
-interacting site suffices for membrane
association if PI4,5P
 
2
 
 levels become sufficiently elevated, as
happens broadly at the PM when COS-7 cells are artificially
and powerfully stimulated by PMA. This motif also contrib-
utes to PLD1 interactions with perinuclear vesicles because a
weakened association with these vesicles is observed even in
resting cells when the PI4,5P
 
2
 
-interacting site is crippled
(Fig. 3 C); and (3) The PX- and PH-mediated interactions
do not suffice to localize PLD1 to the PM because PMA-
promoted attempted translocation of PLD1 to the PM
largely fails (i.e., it redistributes into the cytoplasm) when
the PI4,5P
 
2
 
-interacting site is crippled (Fig. 3 C).
PC12 cells cultured in 15% serum could be in a state of
modest activation in comparison to serum-starved COS-7
cells (although less so than PMA-stimulated COS-7 cells).
Alternatively, there may be cell type–specific differences
that affect how PLD1 localizes in each cell type. For PC12
cells as assayed here, the PI4,5P
 
2
 
 interaction is critical (Vi-
tale et al., 2001), but not sufficient (Fig. 8) for PM localiza-
tion because the PX domain is also required. Interestingly,
once depolarization occurs, the PX domain contribution is
no longer required. A possible explanation is that depolar-
ization leads to increased levels of PI4,5P
 
2
 
 at the PM. In-
deed, PI4,5P
 
2
 
 located at the PM is important for exocytosis
in mast and PC12 cells (Holz et al., 2000; Way et al.,
2000). Moreover, it has been proposed that the docking
and fusion sites for exocytosis are defined by PI4,5P
 
2
 
-con-
taining lipid rafts at the PM that allow structural and spa-
tial organization of the secretory machinery (Chamberlain
et al., 2001; Lang et al., 2001). PLD1 entry into these exo-
cytotic sites as mediated by the palmitoylated PH domain
may be required for the PI4,5P
 
2
 
-interacting residues to
have access to the sites at which PI4,5P
 
2
 
 is accumulating.
Because PA activates PI5K, which generates PI4,5P
 
2
 
, the
recruitment of PLD1 into rafts may lead to a PI4,5P
 
2
 
/
PLD1 positive feedback loop that facilitates exocytosis.
These ideas are supported by the observation that PLD1
lacking palmitoylation (C240,241S) falls into the cyto-
plasm and fails to promote exocytosis on depolarization
(Fig. 8). This suggests that the translocation into rafts is re-
quired for PLD to mediate its function in regulated exocy-
tosis, and that the environment for PM association outsideT
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of the rafts becomes less hospitable because either the PX-
interacting protein or lipid becomes less accessible, or
PI4,5P2 levels diminish. In contrast, PMA stimulation of
COS-7 cells leads to generalized increases in PI4,5P2 across
the PM, and thus entry into lipid rafts is not required for
the PI4,5P2-interacting site to promote PM localization of
PLD1 in that setting.
PX domain interactions
Our findings suggest that the PX domain may mediate more
than one type of association. In resting cells, the PX domain
promotes association with cytosolic vesicles (Fig. 5). This as-
sociation is not disrupted by mutation of amino acids pre-
dicted to interact with phospholipids (e.g., R118), nor does
it depend on interactions with PI3 kinase products. This
suggests that the interaction may be mediated through asso-
ciation with an unknown protein partner and is consistent
with recent papers that have reported that the region encom-
passing the PLD1 PX domain may interact with specific
protein targets such as  -actinin (Park et al., 2000), PKC
(Sung et al., 1999b), and PKN (Oishi et al., 2001).
In contrast, the PX domain is also required for PLD1 in-
ternalization subsequent to cellular stimulation (Fig. 4),
and in this setting, mutation of phospholipid-interacting
sites do disrupt its function. It has been challenging to gen-
erate the PLD1-PX domain in a soluble form; many ap-
proaches that succeeded for PX domains from other pro-
teins yielded only insoluble protein for the PLD1-PX
domain (unpublished data). A soluble protein was gener-
ated in fusion with the bacterial Nus protein, and although
the Nus protein itself exhibited binding to PI3P and PI4P
precluding further assessment of these lipids, the PLD1–
Nus fusion protein did promote specific binding to PI5P.
PI5P has recently garnered attention as a lipid that accumu-
lates during endocytosis as PI4,5P2 is dephosphorylated on
the 4 position (Terebiznik et al., 2002). It is tempting to
propose that PLD1 associated with the PM through inter-
action between PI4,5P2 and PLD1’s PI4,5P2-interacting
motif shifts to vesicles undergoing internalization via its PX
domain as the levels of PI4,5P2 on the PM, and vesicles fall
and the levels of PI5P on vesicles rise. There is precedence
for the first aspect of this idea: generation of PI4,5P2 at the
PM is thought to recruit PH domain–containing proteins
required for endocytosis (Lemmon and Ferguson, 2000);
this PI4,5P2 then becomes hydrolyzed once the endocytic
vesicles are fully formed. This eliminates the recruiting sig-
nal, allowing the endocytic proteins to recycle back to the
PM through diffusion or association with other lipid or
protein targets traveling in the opposite direction. We
would propose that PLD1 also becomes recruited to the
sites of endocytosis through PI4,5P2 elevation; but then in-
stead of abandoning the endocytic vesicles as the PI4,5P2 is
hydrolyzed, it remains associated through PX domain–
mediated association with PI5P.
Finally, the PX domain can undergo reversible phosphor-
ylation at the PM (Kim et al., 2000). This, or interactions
with cytoskeletal or signaling proteins (Sung et al., 1999b;
Park et al., 2000; Oishi et al., 2001), may help regulate the
translocation steps it affects during agonist signaling events.
PH domain and palmitoylation
Ktistakis and coworkers had reported that loss of palmitoyla-
tion at the C240/241 pair of cysteine residues in the PLD1 PH
domain caused it to become retargeted from the perinuclear
vesicle population to the PM, and suggested that regulated
palmitoylation controlled its localization (Sugars et al., 1999).
However, a paradoxical aspect of that model was that palmitate
is generally added, not removed, at the PM, making it unclear
how the regulation would take place. Here, we would propose
instead an alternate model based on a recent observation that
addition of two or more palmitates to proteins drives their ac-
cumulation in lipid rafts (Zacharias et al., 2002), in which
wild-type PLD1 can also be found (Kim et al., 2000). In this
model, PLD1 would be constitutively palmitoylated. On ar-
rival to the PM, it would rapidly localize to lipid rafts and then
reenter the cell. Accordingly, the C240/241 mutation would
block PLD1 entry into rafts and its subsequent internalization.
Our findings in Fig. 6 C demonstrated that entry of PLD1
into lipid rafts via palmitoylation is a critical step in its inter-
nalization in COS-7 cells. Endocytosis from lipid rafts is gen-
erally considered to be clathrin-independent (Nichols, 2002);
PLD1 may be restricted to this route of reentry, in contrast to
PLD2, which has been shown to associate and enter with the
insulin receptor (Rizzo et al., 1999, 2000) during its clathrin-
dependent endocytosis (Ceresa et al., 1998).
Although we have discussed primarily the role of palmi-
toylation in this report, it is possible that the PH domain
may mediate other interactions as well. It was recently re-
ported that the oxysterol binding protein PH domain is tar-
geted to the Golgi through interaction with PI4P and as well
an ARF-dependent determinant, suggesting that its or-
ganelle-specific localization ensues from combinatorial sig-
nals (Levine and Munro, 2002).
The cycling steps we propose for PLD1 are summarized in
Fig. 9. Key observations were similar in COS-7 and PC12,
although there were some differences as well. Whether this
reflects the different culture and stimulatory conditions used
or whether it indicates that the PX, PH, and PI4,5P2 associa-
tions combine to play out somewhat differently in different
cell types remains to be determined. Further clarification and
extension of the proposed model will come from identifying
the relevant protein and/or lipid targets with which PLD1 in-
teracts, and from following PLD1 trafficking in real time
from selected compartments using photoactivatable alleles.
Materials and methods
General reagents
All phospholipids were purchased from Avanti Polar Lipids, Inc. PI4,5P2
was isolated as described previously (Frohman et al., 2000). L–Dipalmitoyl
phosphatidylcholine [choline-methyl-3H] ([3H]phosphatidylcholine) was
obtained from American Radiolabeled Chemicals, Inc. All cell culture me-
dia (DME and Opti-MEM
®-I) and LipofectAMINE™ Plus were from GIBCO
BRL. Wortmannin and methyl- -cyclodextrin were from Sigma-Aldrich.
TLC plates were obtained from Fisher Scientific. SuperSignal
® West Pico
Trial Kit for detection of HRP was from Pierce Chemical Co. All other re-
agents were of analytical grade unless otherwise specified. Membranes
with various phospholipids (PIP-strips) were from Echelon.
Antibodies
3F10 antibody (rat monoclonal anti-HA tag antibody) was from Roche. M2
antibody (mouse monoclonal anti-FLAG tag antibody) was from Sigma-
Aldrich. EEA-1 and GM 130 were from BD Biosciences. Goat anti–mouseT
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IgG conjugated with Alexa
® 488, 568, and 647 were from Molecular
Probes, Inc. Goat anti–rat and anti–mouse IgG conjugated with HRP or
Cy3 were from Jackson ImmunoResearch Laboratories.
Site-directed mutagenesis
Site-directed mutagenesis of expression plasmids was performed using the
QuikChange
® kit (Stratagene). Plasmids were sequenced to confirm the in-
tended mutation and the integrity of the surrounding sequences for at least
500 bp.
Construction of plasmids
All constructs with NH2-terminal appended HA tags were cloned into the
XbaI and XmaI sites of pCGN (for wild-type PLD1, see Hammond et al.,
1995); those with NH2-terminal appended GFP tags were cloned into the
XhoI and XmaI sites of pEGFP-C1 (for wild-type PLD1, see Sung et al.,
1999a); those with COOH-terminal appended GFP tags were cloned into
the HindIII and XmaI sites of pEGFP-N1.
Generation of PLD1 proteins
The generation of viruses for wild-type and inactive (K898R) PLD1 have
been described before (Du et al., 2000). Recombinant bacmids were pre-
pared by transformation of DH10Bac cells with GluGlu-tagged PLD1
R691,695G in pFastBac™. Recombinant baculoviruses were amplified and
propagated using standard procedures. Monolayer cultures of exponentially
growing Sf9 cells were infected with baculoviruses at a multiplicity of 10
and were cultured for 48 h at 27 C. These proteins were purified by affinity
chromatography using an immobilized anti-GluGlu mAb and were eluted
using GluGlu peptide. The concentrations of the proteins were measured by
Coomassie Plus-200 protein assay reagent (Pierce Chemical Co.).
Expression and purification of the PLD1 PX domain
The PLD1 PX domain (aa 77–212) was cloned into the SacI and HindIII
sites of pET43.1a, which encodes Nus and 6xHis tags at its NH2 terminus,
and transformed into Escherichia coli BL21(DE3). Cells were grown at
37 C to A600 0.5–0.6 and induced with 0.5 mM isopropyl-D-thiogalacto-
side for 4 h at 30 C. Cells were lysed by lysozyme/sonication in extraction
buffer (25 mM Tris-HCl, pH 8.0, 150 mM NaCl, and protease inhibitor
cocktail), and was then cleared by centrifugation. The supernatant was in-
cubated with Ni
2 -nitrilotriacetic acid agarose beads (QIAGEN) at 4 C for
1 h. After several washes, the recombinant proteins were eluted from the
beads with elution buffer (25 mM Tris-HCl, 150 mM NaCl, and 250 mM
imidazole, pH 8.0).
Cell culture and transfection
COS-7 cells were maintained in DME supplemented with 10% FBS, 100
U/ml penicillin, and 100 mg/ml streptomycin. For transfection, the cells
were grown in 6-well plates or 35-mm dishes (3–4   10
5 cells/dish), trans-
fected with 1  g of DNA/dish using LipofectAMINE™ Plus for 4 h, and
then switched into complete DME for a further 24 h. For PMA stimulation,
the COS-7 cells were serum starved overnight in DME medium containing
0.2% BSA, starting 20 h after transfection. The cells were then stimulated
with 100 nM PMA for 2 or 4 h. PC12 cells grown on poly-D-lysine–coated
glass coverslips were maintained in Locke’s solution or stimulated with el-
evated K
  (Locke’s containing 59 mM KCl and 85 mM NaCl).
Western analysis
Protein samples or cell lysates from transfected COS-7 cells were mixed
with equal volumes of 2  loading buffer containing 8 M urea, separated
by 8% SDS PAGE, transferred to nitrocellulose membrane, and detected
using a rat anti-HA monoclonal (3F10) or a rabbit anti-PLD1 COOH termi-
nus polyclonal antisera, followed by HRP-conjugated secondary antibod-
ies. The immunoreactive bands were visualized with SuperSignal
® West
Pico Chemiluminescent Substrate (Pierce Chemical Co.).
Confocal and fluorescent microscopy
For live cell studies, COS-7 cells grown on 6-well plates were transiently
transfected with pEGFP constructs. 20–24 h after transfection, the cells
were treated with wortmannin for 0.5 or 1 h Images were taken before and
after treatment on an inverted fluorescent microscope (Eclipse TS100; Ni-
kon) using a digital camera (Coolpix 990; Nikon).
For all other images, COS-7 cells were cultured on coverslips and trans-
fected. 20–24 h after transfection, the cells were fixed with 2% PFA for 10
min and stained. In brief, the cells were permeabilized with 0.1% Triton
X-100 for 10 min and blocked with 5% BSA and normal goat serum. The
cells were then immunostained using primary antibodies against the spe-
cific proteins, followed by fluorescent dye–conjugated secondary antibod-
ies. All experiments were performed at least three times with similar results.
Quantification of the localization of PLD1 alleles was performed using a
40  dry lens with a fluorescent microscope (model BX 60; Olympus). All
experiments were repeated at least three times. At least 300 cells were ran-
domly selected and scored for localization for each sample. The results de-
scribed present the mean and SD.
PC12 cells were fixed, permeabilized, and immunostained as described
previously (Vitale et al., 2001). Stained cells were visualized using a confo-
cal microscope (LSM 510; Carl Zeiss MicroImaging, Inc.).
PLD activity and exocytosis assays
PLD activity assays were performed using the in vitro head-group release
assay for a 30-min time period (Morris et al., 1997). Recombinant ARF1
Figure 9. A model for regulated cycling of PLD1. See Discussion 
for details. In brief, in quiescent COS-7 cells, PLD1 localizes to a 
complex set of perinuclear and cytosolic vesicles (top schema, heavy 
black circle). This is mediated by a non-PI interaction by the PX 
domain, the palmitoylated PH domain, and weak interactions with 
PI4,5P2 by the central basic amino acid–rich motif, although the 
different domains most likely preferentially target distinct subpopu-
lations of vesicles. In PC12 cells, a combination of PX domain 
interactions and interactions with PI4,5P2 suffice to recruit PLD1 to 
the PM (bottom schema, heavy black circle). With higher levels of 
stimulation, such as exposure to PMA for COS-7 cells, the PI4,5P2 
interaction alone suffices to promote PM association. However, to 
reenter the cell with normal kinetics, PLD1 needs to enter into lipid 
rafts, and for this, the PH domain to be palmitoylated. Once in rafts, 
the PX domain association with the PM ceases; but a new PI-dependent 
interaction takes place, potentially through the binding of PX to PI5P, 
which facilitates translocation of PLD1 to vesicles internalizing 
through endocytosis. In PC12 cells, secretagogue-evoked stimulation 
(depolarization) recruits PLD1 into sites of active exocytosis, which 
are found in rafts and are marked by increased levels of PI4,5P2. 
Palmitoylation of the PH domain is similarly required for this 
recruitment, but once it happens, the PX domain interaction is no 
longer required for membrane association or for PLD1 functional 
promotion of exocytosis. How PLD1 returns to its original location 
remains to be determined.T
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proteins were purified and were activated using 50  M GTP S as de-
scribed previously (Du et al., 2000). PC12 exocytosis assays were per-
formed as described previously (Vitale et al., 2001). PC12 exocytosis was
monitored using ectopically expressed human growth hormone (hGH) as a
reporter. In brief, cells were cotransfected with pXGH5 together with a
plasmid encoding PLD1 or a tagged allele. 48 h after transfection, cells
were washed in Locke’s solution and incubated for 10 min in Locke’s solu-
tion or elevated K
 . Cell-free supernatant was collected to represent the se-
creted hGH fraction. Cells were scraped and lysed to obtain the nonse-
creted fraction. hGH in each fraction was measured by radioimmunoassay
(Vitale et al., 2001).
Liposome binding assay
The method has been described previously (Sciorra et al., 1999; Du et al.,
2002). In brief, sucrose-loaded phospholipid vesicles containing equal
molar amounts of phosphatidylcholine, phosphatidylserine, and phos-
phatidylethanolamine, and 5% PI4,5P2 were prepared and resuspended in
buffer containing 100 mM KCl and 1 mM MOPS. PLD1 proteins were
mixed with the vesicles in siliconized tubes and incubated on ice for 30
min. The vesicles were sedimented by centrifugation at 30,000 g for 1 h.
The pelleted vesicles were resuspended in 100  l MOPS buffer. The distri-
bution of the wild-type and mutant PLD1 proteins in the supernatant and
pellet was analyzed by Western blotting.
Protein-lipid overlay assay
Membranes spotted with assorted phospholipids (PIP-strips) were blocked
in 3% fatty acid–free BSA in TBST buffer (50 mM Tris-HCl, 150 mM NaCl,
and 0.1% Tween 20, pH 7.5) for 1 h at RT. The membranes were then in-
cubated overnight at 4 C in the same solution with 0.2  g/ml Nus or Nus-
tagged protein. Bound protein was detected using an anti-Nus mAb/HRP-
conjugated goat anti–mouse secondary antibody.
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